Whan In Pharm Co.,Ltd. (KRX:016580)
South Korea flag South Korea · Delayed Price · Currency is KRW
9,840.00
-160.00 (-1.60%)
Aug 21, 2026, 3:30 PM KST

Whan In Pharm Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
56,62763,58043,14745,36636,77664,056
Short-Term Investments
22514051915,16412,79122,966
Trading Asset Securities
9,790-8,91517,92737,72558,940
Cash & Short-Term Investments
66,64263,72052,58178,45787,292145,962
Cash Growth
45.04%21.18%-32.98%-10.12%-40.20%24.80%
Accounts Receivable
66,41961,87670,98374,52668,24261,876
Other Receivables
4,4704,6004,6444,3404,0211,243
Receivables
71,04366,54775,70978,94772,32663,201
Inventory
100,37696,32272,41154,05837,06032,745
Prepaid Expenses
1,9281,674462.1501.07426.78334.39
Other Current Assets
147.457.97134.39138.51317.02169.72
Total Current Assets
240,136228,271201,297212,101197,422242,412
Property, Plant & Equipment
140,843144,059149,218131,211109,85446,869
Long-Term Investments
56,42462,98132,74919,16323,90126,193
Other Intangible Assets
9,0849,2927,1605,3823,1762,969
Long-Term Deferred Tax Assets
3,7511,9471,899171.91--
Other Long-Term Assets
32,01132,33432,36233,15935,00234,715
Total Assets
482,626478,891424,706401,227369,375353,189

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
27,70823,21322,45618,07111,9669,422
Accrued Expenses
3,1333,9203,0493,2242,4734,171
Current Portion of Leases
410.88396.51278.24324.97186.32415.86
Current Income Taxes Payable
4,8436,7432,6362,6833,3305,571
Other Current Liabilities
20,30822,22913,95715,72513,79611,320
Total Current Liabilities
56,40356,50142,37640,02831,75030,900
Long-Term Leases
157.11282.48135.5307.0663.621,305
Long-Term Deferred Tax Liabilities
----368.341,098
Other Long-Term Liabilities
592.091,1006,1922,6843,2642,660
Total Liabilities
57,15257,88448,70443,01935,44635,963

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
9,7009,7009,7009,7009,7009,700
Additional Paid-In Capital
42,52142,52121,06221,06220,81721,135
Retained Earnings
377,769368,149358,861339,984314,790295,449
Treasury Stock
-336.88-336.88-9,669-9,669-9,669-9,669
Comprehensive Income & Other
-4,180972.93-3,952-2,870-2,126324.92
Total Common Equity
425,474421,007376,002358,207333,511316,939
Minority Interest
----416.75286.26
Shareholders' Equity
425,474421,007376,002358,207333,928317,226
Total Liabilities & Equity
482,626478,891424,706401,227369,375353,189

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
567.99679413.74632.03249.941,721
Net Cash (Debt)
66,07463,04152,16777,82587,042144,241
Net Cash Growth
46.59%20.84%-32.97%-10.59%-39.66%25.68%
Net Cash Per Share
3782.743975.803416.995097.575701.299447.84
Filing Date Shares Outstanding
18.4618.4815.2715.2715.2715.27
Total Common Shares Outstanding
18.4618.4815.2715.2715.2715.27
Working Capital
183,733171,769158,921172,074165,671211,512
Book Value Per Share
23044.7722776.9024628.2723462.7521845.1520759.68
Tangible Book Value
416,390411,715368,841352,826330,335313,970
Tangible Book Value Per Share
22552.7622274.1724159.2723110.2421637.1120565.20
Land
49,67749,67749,67749,57249,72613,536
Buildings
71,07471,07471,07440,93835,82124,194
Machinery
27,36927,22725,82222,09418,65310,919
Construction In Progress
303.6825.6103.4518,8767,5904,610